South Carolina moves closer to legalizing medical cannabis

Be at the forefront of the latest cannabis scientific research. Submit a research abstract to present by Dec. 16, or register to attend the The Emerald Conference by MJBizScience, March 1-3 in San Diego.

 


The South Carolina Legislature is poised to legalize medical cannabis, but the bill that could make that happen might still fail.

The measure in question – S. 150 – has passed the state Senate and was approved easily Thursday by a House committee after a few amendments, the Associated Press reported.

That action set the stage for a full House floor vote.

However, the Associated Press noted, the bill has both bipartisan support and opposition in the House, making the measure’s ultimate fate still unclear.

If the bill were to pass and ultimately become law, it would establish the latest MMJ market in the South – and a very restrictive one.

Under the bill, marijuana flower would remain prohibited, and the list of qualifying medical conditions for registered patients would be relatively thin, including only:

  • Autism
  • Cachexia or wasting syndrome
  • Cancer
  • Chronic muscle spasms
  • Crohn’s disease
  • Epilepsy or another seizure disorder
  • Multiple sclerosis
  • Persistent nausea for hospice or homebound patients
  • Post-traumatic stress disorder
  • Sickle cell anemia
  • Ulcerative colitis

Get the MJBizDaily Extraction Buyers Guide, now available.

This free resource offers practical business tips and valuable insights from cannabis extraction professionals to help plan or scale your extraction or processing operation with confidence.

Inside the MJBizDaily Extraction Buyers Guide:
  • In-depth guidance for planning a CBD extraction business
  • Best practices in sourcing solvents + solventless materials
  • Lessons in shopping for extraction/processing equipment
  • Tips for outfitting a facility for psilocybin mushroom extraction
  • And more!

The only medical marijuana products allowed would be oils, salves, patches or vaporizers, the AP reported, and only a select few pharmacies would be permitted to sell them, akin to Louisiana’s MMJ industry structure.

Also, South Carolina patients would be allowed to purchase only up to a two-week supply of medicine at a time.